Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Ona’s €30m Series A round: directly targeting metastasis in cancer

Slightly over a year since its launch, Ona has raised €30m in a Series A round. This funding will be used to advance the company’s work on preventing and treating metastasis in various cancer types and overcoming a significant unmet need in oncology.

Close
Close
Close

Go Top